A Case Report on Alport Syndrome which ends up with Allograft Rejection due to Anti-GBM Disease

Authors

  • Ansu Ann Mathew Rajiv Gandhi university

DOI:

https://doi.org/10.37591/rrjom.v9i3.1778

Abstract

Alport syndrome (AS) is a condition which is genetically inherited and is characterized by abnormalities in the basement membrane of the kidney, ear and eye as well. It is one of the spectra of diseases representing hereditary nephritis, which inevitably leads to end-stage renal disease (ESRD). Sensorineural hearing loss (SNHL) is also a characteristic feature in AS. The hearing abnormality begins during late childhood or early adolescence and 90% of the individuals become deaf by the age of 40 years. The chief ocular findings include anterior lenticonus, cataract, central and midperipheral retinal flecks. Other ocular changes include corneal arcus, recurrent corneal erosion, posterior lenticonus, posterior polymorphus dystro­phy and macular degeneration; finally, they end up with vision loss. Here I report a case of AS with all the characteristic features.

 

Keywords: Alport syndrome (AS), hematuric nephritis, sensorineural deafness, anterior lenticonus, proteinuria

 

Cite this Article

Ansu Ann Mathew A Case Report on Alport Syndrome which ends up with Allograft Rejection due to Anti-GBM Disease. Research & Reviews: Journal of Medicine. 2019; 9(3): 1–4p.

Downloads

Published

2019-11-12

Issue

Vol. 9 No. 3 (2019)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.